CAPE TOWN - South Africa’s largest pharmaceutical group and JSE-listed company, Aspen Pharmacare has launched a R1 billion high containment manufacturing facility in Port Elizabeth which will create an additional 500 jobs.
The pharmaceutical giant has added a sixth production facility at its manufacturing site in the Eastern Cape. The group which has a global presence in 50 countries, aims to target the export market with its new high potency facility.
The 23,000m² facility will produce 3.2 billion tablets a year on level 1 of the facility with 3 million bottles being packaged per month.
Meanwhile, an added 400 million tablets a year with bottle packing capability will be produced on the second level of the facility.
Chief executive of Aspen Pharmacare, Stephen Saad said that the facility is a significant investment in the South African pharmaceutical industry. The company, which grew from a two-bedroom house in Durban is now a globalised multinational company.